An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT03611751 · COMPLETED
Trial details
- NCT number
- NCT03611751
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-26
- Primary completion
- 2020-11-29
- Enrollment
- 1020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.